Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-04-19
2011-04-19
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S363000
Reexamination Certificate
active
07928108
ABSTRACT:
The invention provides 3-(methyloxy)-1-{4-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]butyl}-2(1H)-pyridinone of formula (I),or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: WO 2004/046124 (2004-06-01), None
Waldinger et al. Expert Opin.Emerging Drugs, vol. 11(1): 99-109 (2006).
Gentile Gabriella
Zucchelli Valeria
Bernhardt Emily
Fitch Duke M.
Glaxo Group Limited
Lemanowicz John
Sieburth Kathryn L.
LandOfFree
Pyridinone derivative for the treatment of premature... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridinone derivative for the treatment of premature..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridinone derivative for the treatment of premature... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2699555